Ardelyx Plans Mid-2020 NDA Filing For Tenapanor In Hyperphosphatemia

 
• By Jessica Merrill
  
SC1912_Success_325170179_1200.jpg
Aredlyx's tenapanor was successful in a second Phase III trial • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business